{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:20:33Z","timestamp":1791390033114,"version":"4.3.3"},"reference-count":17,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":113,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Botulinum toxin type A (BTA) is commonly used to treat dystonia; however, reports of dystonia caused by BTA are rare. In this case study, the authors aimed to illustrate the instances of dystonia after cosmetic injections of BTA. Three cases were retrospectively analyzed, with follow-up evaluations conducted to assess the development and resolution of symptoms. Injection techniques, including microdroplet and intradermal methods, were examined, and potential hypotheses regarding the etiology of dystonia were explored. Recommendations for mitigating adverse effects were formulated based on the analysis of injection practices, including modifications to dosage, injection-site distribution, and volume. In all cases, patients experienced transient dystonia following BTA injections, with symptoms including muscle spasms and abnormal muscle contractions, which resolved spontaneously or with minor interventions. The findings suggest that the use of microdroplet techniques and careful injection strategies can minimize the risk of such adverse effects. In conclusion, the authors suggest that neurological injury, neuromuscular junction impact, uneven drug distribution, and imbalance between denervation and functional recovery may cause dystonia.<\/jats:p>\n               <jats:sec>\n                  <jats:title>Level of Evidence: 5 (Diagnostic)<\/jats:title>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/asjof\/ojaf027","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:51:25Z","timestamp":1745473885000},"source":"Crossref","is-referenced-by-count":3,"title":["Myospasm and Fasciculation After Botulinum Toxin Injection"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-6119","authenticated-orcid":false,"given":"Xueqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"2025061105120822100_ojaf027-B1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00702-020-02266-z","article-title":"Botulinum toxin therapy of dystonia","volume":"128","author":"Dressler","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"key":"2025061105120822100_ojaf027-B2","doi-asserted-by":"publisher","first-page":"NP327","DOI":"10.1093\/asj\/sjac036","article-title":"Complications of cosmetic botulinum toxin A injections to the upper face: a systematic review and meta-analysis","volume":"42","author":"Zargaran","year":"2022","journal-title":"Aesthet Surg J"},{"key":"2025061105120822100_ojaf027-B3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3346\/jkms.1993.8.5.334","article-title":"Botulinum a toxin treatment of hemifacial spasm and blepharospasm","volume":"8","author":"Park","year":"1993","journal-title":"J Korean Med Sci"},{"key":"2025061105120822100_ojaf027-B4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cxom.2022.09.007","article-title":"Botulinum toxin in facial reanimation: map of the facial musculature and dosage","volume":"31","author":"VandeWater","year":"2023","journal-title":"Atlas Oral Maxillofac Surg Clin North Am"},{"key":"2025061105120822100_ojaf027-B5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/toxins12020112","article-title":"Use of botulinum toxin in orofacial clinical practice","volume":"12","author":"Serrera-Figallo","year":"2020","journal-title":"Toxins (Basel)"},{"key":"2025061105120822100_ojaf027-B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines","volume":"51","author":"Ascher","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2025061105120822100_ojaf027-B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.asj.2005.05.004","article-title":"Botulinum toxin A in the treatment of glabellar lines: scheduling the next injection","volume":"25","author":"Ascher","year":"2005","journal-title":"Aesthet Surg J"},{"key":"2025061105120822100_ojaf027-B8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1111\/j.1524-4725.2009.01235.x","article-title":"Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety","volume":"35","author":"Brandt","year":"2009","journal-title":"Dermatol Surg"},{"key":"2025061105120822100_ojaf027-B9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/j.1524-4725.2005.31206","article-title":"Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids","volume":"31","author":"Carruthers","year":"2005","journal-title":"Dermatol Surg"},{"key":"2025061105120822100_ojaf027-B10","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/PRS.0b013e3181b5641b","article-title":"Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study","volume":"124","author":"Kane","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"2025061105120822100_ojaf027-B11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/jocd.13437","article-title":"Paradoxical bulging of mentalis after botulinum toxin type A injection","volume":"19","author":"Yu","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"2025061105120822100_ojaf027-B12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1055\/s-0043-1770078","article-title":"Hyaluronic acid filler injection guided by Doppler ultrasound","volume":"50","author":"Lee","year":"2023","journal-title":"Arch Plast Surg"},{"key":"2025061105120822100_ojaf027-B13","doi-asserted-by":"publisher","first-page":"e4865","DOI":"10.1097\/GOX.0000000000004865","article-title":"Central forehead ischemic skin injury following glabellar botulinum: a paradigm microshift?","volume":"11","author":"Hynes","year":"2023","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2025061105120822100_ojaf027-B14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3760\/cma.j.cn114453-20210425-00181","article-title":"Anatomic research on temporal branches of facial nerve","volume":"39","author":"Zhang","year":"2023","journal-title":"Chin J Plast Surg"},{"key":"2025061105120822100_ojaf027-B15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MOO.0000000000000920","article-title":"Minimization of facial synkinesis","volume":"31","author":"Tikhtman","year":"2023","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2025061105120822100_ojaf027-B16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10072-017-3191-3","article-title":"Longitudinal neurophysiological assessment of intramuscular type-A botulin toxin in healthy humans","volume":"39","author":"Lispi","year":"2018","journal-title":"Neurol Sci"},{"key":"2025061105120822100_ojaf027-B17","doi-asserted-by":"publisher","first-page":"322e","DOI":"10.1097\/PRS.0000000000010469","article-title":"Anatomical proposal for botulinum neurotoxin injection for horizontal forehead lines","volume":"153","author":"Yi","year":"2024","journal-title":"Plast Reconstr Surg"}],"container-title":["Aesthetic Surgery Journal Open Forum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asjopenforum\/advance-article-pdf\/doi\/10.1093\/asjof\/ojaf027\/62996058\/ojaf027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojaf027\/62996058\/ojaf027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojaf027\/62996058\/ojaf027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:12:15Z","timestamp":1749633135000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article\/doi\/10.1093\/asjof\/ojaf027\/8118885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":17,"URL":"https:\/\/doi.org\/10.1093\/asjof\/ojaf027","relation":{},"ISSN":["2631-4797"],"issn-type":[{"value":"2631-4797","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"ojaf027"}}